CTIS2023-506295-26-00招募中1 期
Evolution of proteinuria in renal transplant patients treated with Dapagliflozin for nephroprotection. DAPAGREFFE - RECHMPL23_0102
niversity Hospital Of Montpellier0 个研究点目标入组 70 人开始时间: 2023年7月13日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Initiation of dapagliflozin less than 14 days ago for chronic kidney disease, eGFR (by CKD-EPI) between 25 and 75 ml.min.1.73m², Albuminuria/Creatinuria ratio between 200 mg/g and 5000 mg/g, Treatment with an ACE inhibitor or angiotensin 2 receptor blocker (ARA II or sartan) at the maximum tolerated dose for at least 4 weeks, Age = 18 years, For CKD Renal Transplant Recipients: kidney transplant more than one year
排除标准
- •Guardianship or trusteeship, Patient undergoing treatment with another SGLT2 inhibitor (sodium-glucose co-transporter type 2), Patient enrolled in another clinical trial, Pregnancy or breast-feeding, Patient protected by law, Subject not affiliated to a social security scheme, or not benefiting from such a scheme, Patient deprived of liberty, For the control group (non-transplanted CKD) : history of transplantation, Initiation or modification of immunosuppressive therapy less than 6 months ago (except temporary discontinuation for infection or change in dosage), Type 1 diabetes, Severe liver failure (Child-Pugh stage C), Intolerance to any of the excipients of Forxiga®, in particular lactose intolerance
研究者
相似试验
招募中
不适用
Proteinuria in Deceased Kidney Transplant Donors for Prediction of Chronic Lesions in Pre-Transplant Biopsies – a prospective multi-center studyZ94.0Kidney transplant statusDRKS00031008Medizinische Universität Wien300
已完成
不适用
Proteinuria in Renal Transplant Patients Treated With DapagliflozinChronic Kidney DiseasesNCT06165601University Hospital, Montpellier55
尚未招募
不适用
Developing a non-invasive method for the diagnosis and monitoring of kidney transplant rejectioEnd stage kidney diseaseKidney transplantationKidney transplant rejectionRenal and Urogenital - Kidney diseaseACTRN12621000898853Royal Melbourne Hospital300
Unknown
不适用
Renal Transplant Patient Protein Oxidation Studyprotein, metabolism, breath test, oxidationNL-OMON25890niversity Medical Center Groningen32
撤回
不适用
Protein oxidation in stable renal transplant patients measured with a breath testNL-OMON46350niversitair Medisch Centrum Groningen32